Source comparison
Tesamorelin for Andropause: Comparison with Alternative Interventions
The following table compares tesamorelin with the most common alternatives men 45-55 researching andropause consider for visceral adiposity and metabolic decline. Tesamorelin 2mg daily GHRH receptor agonist. Stimulates pulsatile endogenous GH secretion 15.2% a
This comparison does not assign a generated winner or score.
- The following table compares tesamorelin with the most common alternatives men 45-55 researching andropause consider for visceral adiposity and metabolic decline.
- Tesamorelin 2mg daily
- GHRH receptor agonist. Stimulates pulsatile endogenous GH secretion
- 15.2% at 26 weeks (JCEM trial)
- No suppression. Operates independently of HPG axis
- $400-$600
- Most direct visceral adiposity intervention. Preserves endogenous hormone production
- Exogenous GH 0.3-0.5mg daily
- Direct GH receptor activation. Bypasses pituitary regulation
- 10-14% at 24 weeks (varies by dose)
- May suppress GnRH pulsatility in 15-20% of users
- $800-$1200
- Effective but non-physiological. Higher side effect risk (oedema, insulin resistance)
- Testosterone Replacement (TRT)
- Androgen receptor activation in muscle and subcutaneous fat
- 0-2% visceral fat (minimal effect per meta-analysis)
- Suppresses endogenous testosterone. Requires lifelong therapy
- $150-$300
- Corrects hypogonadal symptoms but doesn't address GH-independent fat distribution
- GLP-1 Agonist (semaglutide 2.4mg weekly)
- Delays gastric emptying and suppresses appetite via incretin signalling
- 8-12% total body fat. Visceral component not specifically measured
- No effect on testosterone or GH
- $900-$1200
- Potent weight loss but mechanism is caloric restriction. Doesn't restore hormone pulsatility
- Metformin 1500-2000mg daily
- AMPK activation. Improves insulin sensitivity in liver and muscle
- 2-4% total body fat (indirect via improved glucose disposal)
- No direct effect
- $10-$30
- Minimal visceral fat effect. Better suited as metabolic support alongside hormonal intervention